You are here

Verily

7 Big Moments for Surgical Robotics in 2019

7 Big Moments for Surgical Robotics in 2019

Medical Devices and Diagnostics Industry

robotic surgery

Intuitive Surgical

Flag link:

Verily lures major pharmas with promise of speedier clinical research

Verily lures major pharmas with promise of speedier clinical research

BioPharma Dive

clinical trials

Flag link:

Google Jumps Into Gene Editing: 5 Things You Need to Know

Google Jumps Into Gene Editing: 5 Things You Need to Know

Motley Fool

Verve Therapeutics

Flag link:

Verily builds US drug rehab campus amid opioid crisis

Verily builds US drug rehab campus amid opioid crisis

Pharmaforum

Kettering Health Netwok

Flag link:

Alphabet’s smart watch ECG gets FDA backing

Alphabet’s smart watch ECG gets FDA backing

Pharmaforum

Flag link:

Alphabet’s Biotech R&D Arm Verily Raises $1B to Fuel Growth

Alphabet’s Biotech R&D Arm Verily Raises $1B to Fuel Growth

Xconomy

Flag link:

It's Lights Out For Novartis And Verily's Glucose Monitoring 'Smart Lens' Project

It's Lights Out For Novartis And Verily's Glucose Monitoring 'Smart Lens' Project

Forbes

blood glucose monitoring

Flag link:

ResMed, Google’s Verily ink sleep-apnea-focused joint venture deal

ResMed, Google’s Verily ink sleep-apnea-focused joint venture deal

Mass Device

Flag link:

Sensile, Sanofi, and Verily Form Diabetes Dream Team

Sensile, Sanofi, and Verily Form Diabetes Dream Team

Medical Devices and Diagnostics Industry

Sensile Medical

insulin patch pump

Flag link:

Is Verily Making a Blood Collection Device Involving 'Exploding' Micro-Needles?

Is Verily Making a Blood Collection Device Involving 'Exploding' Micro-Needles?

Medical Devices and Diagnostics Industry

blood collection

Flag link:

Gilead and Alphabet's Verily to Collaborate on Research in Immunological and Molecular Drivers of Inflammatory Diseases

Gilead and Alphabet's Verily to Collaborate on Research in Immunological and Molecular Drivers of Inflammatory Diseases

CP Wire

Gilead Sciences

rheumatoid arthritis

inflammatory bowel disease

Flag link:

Gilead and Alphabet's Verily to Collaborate on Research in Immunological and Molecular Drivers of Inflammatory Diseases

Flag link:

Five Events That Disrupted the Diabetes Market

Five Events That Disrupted the Diabetes Market

Medical Devices and Diagnostics Industry

blood glucose monitoring

artificial pancreas

FreeStyle Libre Flash

Flag link:

A Potential $1 Trillion Healthcare Market -- and Alphabet Wants a Piece of It

A Potential $1 Trillion Healthcare Market -- and Alphabet Wants a Piece of It

Motley Fool

population health

Flag link:

Apple, JNJ, Roche among companies selected for FDA digital health precertification pilot

Apple, JNJ, Roche among companies selected for FDA digital health precertification pilot

BioPharma Dive

digital healthcare

Flag link:

3 Ways AI Is Changing Medicine

3 Ways AI Is Changing Medicine

Motley Fool

artificial intelligence

Gritstone Oncology

cancer immunotherapy

retinal blindness

Flag link:

With Novartis and Google jumping in, Medicxi unveils a $300M late-stage biotech fund with a transatlantic scope

With Novartis and Google jumping in, Medicxi unveils a $300M late-stage biotech fund with a transatlantic scope

Endpoints

Flag link:

Sanofi is teaming with Verily on a $500M JV aimed at marrying tech with diabetes drugs

Sanofi is teaming with Verily on a $500M JV aimed at marrying tech with diabetes drugs

Endpoints

Flag link:

Q&A: Glaxo exec says bioelectronics venture with Verily is ‘not science fiction’

Q&A: Glaxo exec says bioelectronics venture with Verily is ‘not science fiction’

Stat

Flag link:

Google’s Verily and GlaxoSmithKline hatch a $713M plan to spark a biorevolution

Google’s Verily and GlaxoSmithKline hatch a $713M plan to spark a biorevolution

Endpoints

Flag link:

Pages